Oral NMN in healthy men: body temperature and other clinical measures

The study did not demonstrate relief from feeling cold

Although the original headline asks how NMN affects sensitivity to cold, the cited study examined single-dose administration and metabolism in ten healthy Japanese men. Body temperature did not show a significant change.

The study was an early safety-related investigation, not a treatment trial for cold hands, poor circulation or a condition causing temperature sensitivity.

How the study was conducted

Participants received single oral doses of 100, 250 and 500 mg under a non-randomized, single-arm study design. Clinical observations, blood and urine measurements, and metabolite responses were assessed for five hours after each intervention.

Eye examinations and sleep-quality assessments were also performed around the intervention period. These procedures were intended to identify short-term changes, not to establish long-term effectiveness.

Reported results

The investigators did not observe significant clinical symptoms or changes in heart rate, blood pressure, oxygen saturation or body temperature. Some laboratory values changed, including bilirubin, creatinine, chloride and glucose, but the reported changes remained within the relevant normal ranges.

Eye-examination findings and sleep-quality scores did not show a meaningful difference before and after the intervention. Selected nicotinamide metabolites increased in a dose-dependent manner, indicating that the administered compound was metabolized.

What the safety findings mean

The results supported short-term tolerability under the particular conditions studied. Ten selected healthy men observed after single doses cannot establish safety for every population or for daily use over many years.

A metabolite increase is not evidence of a temperature-related benefit. The absence of a temperature change should be retained when interpreting the original headline.

Conclusion

This paper contributes early information about oral NMN metabolism and clinical measurements in healthy men. It does not establish that NMN improves sensitivity to cold, sleep or eye symptoms.

Cited paper: Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.